Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hypoglycemia
Findings from A.B. King and co-authors broaden understanding of hypoglycemia
June 15th, 2009
In this recent article published in the journal Endocrine Practice, scientists in the United States conducted a study "To evaluate the effect of near-normal glucose control before initiation of pramlintide therapy and square-wave meal bolus on self-reported hypoglycemia and the percentage change in dosing parameters after attaining the maximum pramlintide dosage. In this prospective study, insulin pump-treated patients with type 1 diabetes had insulin dosages optimally titrated on the basis of daily continuous glucose monitoring (CGM)." "Pramlintide therapy was initiated, and the dosage was increased 15 meg/meal per week. Insulin dosage was adjusted during...
Source: Diabetes Week (2009-06-15)
|
